Flavopiridol Inactivates P-TEFb and Blocks Most RNA Polymerase II Transcription in Vivo
Top Cited Papers
Open Access
- 1 August 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (34) , 31793-31799
- https://doi.org/10.1074/jbc.m102306200
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Positive Transcription Elongation Factor b Phosphorylates hSPT5 and RNA Polymerase II Carboxyl-terminal Domain Independently of Cyclin-dependent Kinase-activating KinaseJournal of Biological Chemistry, 2001
- DSIF and NELF Interact with RNA Polymerase II Elongation Complex and HIV-1 Tat Stimulates P-TEFb-mediated Phosphorylation of RNA Polymerase II and DSIF during Transcription ElongationJournal of Biological Chemistry, 2001
- Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current statusExpert Opinion on Investigational Drugs, 2000
- Flavopiridol Inhibits P-TEFb and Blocks HIV-1 ReplicationJournal of Biological Chemistry, 2000
- Structure–activity relationship studies of flavopiridol analoguesBioorganic & Medicinal Chemistry Letters, 2000
- Tat Transactivation: A Model for the Regulation of Eukaryotic Transcriptional ElongationVirology, 1999
- Effects of transcription and translation inhibitors on a human gastric carcinoma cell line: Potential role of Bcl-Xs in apoptosis triggered by these inhibitorsBiochemical Pharmacology, 1997
- Phosphorylation dependence of the initiation of productive transcription of balbiani ring 2 genes in living cellsChromosoma, 1996
- Potent Inhibition of Cdc2 Kinase Activity by the Flavonoid L86-8275Biochemical and Biophysical Research Communications, 1994
- Ribosomal RNA synthesis in isolated nucleiJournal of Molecular Biology, 1972